
• | Demonstrated industry-first 400Gbps pulse-amplitude-modulation digital signal processing systems-on-a-chip solutions with integrated laser drivers to address the high-speed optical interconnect needs of mega-scale cloud data centers and network enterprises. |
• | G.hn Wave-2 networking chipset selected by Comtrend for new carrier-grade Wi-Fi connectivity extender solution in the North American service provider market. |
• | Demonstrated NetAerial cord cutter ATSC TV distribution system, which incorporates MaxLinear's ATSC TV tuners and G.hn chipsets, to stream live TV to connected smart devices with Geniatech. |
• | Announced plans to introduce G.hn connectivity solutions for the automotive, industrial, security and utility markets for use in vehicles, industrial products, security cameras, smart meters and other smart grid applications. |
• | Announced collaboration with Airgain Inc. to demonstrate more than 2 Gbps data transfer through low-emissivity glass windows for 5G fixed wireless access with MaxLinear's AirPHY™ wireless modem technology and Airgain's broadband, near-field antenna module. |
• | Commenced shipments of digital satellite low-noise block downconverters and channel stacking ICs to Telefónica with ProBrand International for two South American countries. |
• | Net revenue was $113.7 million, flat sequentially, and up 31% year-on-year. |
• | GAAP gross margin was 45.8%, compared to 45.6% in the prior quarter, and 57.8% in the year-ago quarter. |
• | GAAP operating expenses were $57.8 million in the fourth quarter 2017, or 51% of net revenue, compared to $62.5 million in the prior quarter, and $42.1 million in the year-ago quarter. |
• | GAAP loss from operations was 5% of revenue, compared to loss from operations of 9% in the prior quarter, and income from operations of 10% in the year-ago quarter. |
• | Net cash flow provided by operating activities of $21.7 million, compared to cash flow provided by operations of $37.7 million in the prior quarter and cash flow provided by operating activities of $27.6 million in the year-ago quarter. |
• | GAAP pre-tax losses were 9% of revenue, compared to pre-tax losses that were 14% of revenue in the prior quarter, and pre-tax income that was 10% of revenue in the year-ago quarter. |
• | GAAP income tax provision was 85% of pre-tax loss, including approximately $16.5 million of income tax expense for the recently enacted Tax Cuts and Jobs Act, or Tax Act, primarily associated with reducing the federal tax rate on certain deferred tax assets from 35% to 21%, compared to an income tax benefit of 41% of pre-tax loss in the prior quarter, and income tax provision of 3% of pre-tax income in the year-ago quarter. Excluding the effects of the Tax Act, we would have recorded a tax benefit of approximately 72% of the pre-tax loss for the quarter. |
• | GAAP net loss was $19.4 million, compared to net loss of $9.2 million in the prior quarter, and net income of $8.3 million in the year-ago quarter. |
• | GAAP diluted loss per share was $0.29, compared to loss per share of $0.14 in the prior quarter, and earnings per share of $0.12 in the year-ago quarter. |
• | Non-GAAP gross margin was 62.0%. This compares to 62.5% in the prior quarter (62.1% when calculated to adjust for the prior quarter's $0.8 million of deferred revenue eliminated under Exar acquisition purchase accounting), and 63.9% in the year-ago quarter. |
• | Non-GAAP operating expenses were $38.3 million, or 34% of revenue, compared to $37.9 million or 33% of revenue in the prior quarter, and $30.1 million and 35% of revenue in the year-ago quarter. |
• | Non-GAAP income from operations was 28% of revenue, compared to 29% in the prior quarter, and 29% in the year-ago quarter. |
• | Non-GAAP pre-tax margin was 24% of revenue, compared to 25% in the prior quarter, and 30% in the year-ago quarter. |
• | Non-GAAP effective tax rate was 4% of non-GAAP pre-tax income, compared to 4% in the prior quarter, and 1% in the year-ago quarter. Current quarter non-GAAP effective tax rate is based on year-to-date effective tax rate of 7% of non-GAAP pre-tax income. Effects of the Tax Act were excluded from Non-GAAP effective tax rate. |
• | Non-GAAP net income was $26.3 million, compared to $27.1 million in the prior quarter, and $25.7 million in the year-ago quarter. |
• | Non-GAAP diluted earnings per share was $0.38, compared to diluted earnings per share of $0.39 in the prior quarter, and diluted earnings per share of $0.38 in the year-ago quarter. |
• | GAAP and non-GAAP gross margin of approximately 55% and 63%, respectively. |
• | GAAP and non-GAAP operating expenses of approximately $57.5 million and $39.5 million, respectively. |
• | GAAP and non-GAAP interest and other expenses of approximately $4.2 million. |
• | GAAP tax expense of approximately $0.5 million and non-GAAP cash tax rate of approximately 7%. |
Three Months Ended | |||||||||||
December 31, 2017 | September 30, 2017 | December 31, 2016 | |||||||||
Net revenue | $ | 113,721 | $ | 113,581 | $ | 87,136 | |||||
Cost of net revenue | 61,628 | 61,739 | 36,733 | ||||||||
Gross profit | 52,093 | 51,842 | 50,403 | ||||||||
Operating expenses: | |||||||||||
Research and development | 30,116 | 29,270 | 24,035 | ||||||||
Selling, general and administrative | 26,843 | 29,037 | 16,720 | ||||||||
IPR&D impairment losses | — | 2,000 | — | ||||||||
Restructuring charges | 800 | 2,178 | 1,326 | ||||||||
Total operating expenses | 57,759 | 62,485 | 42,081 | ||||||||
Income (loss) from operations | (5,666 | ) | (10,643 | ) | 8,322 | ||||||
Interest income | 14 | 1 | 146 | ||||||||
Interest expense | (4,044 | ) | (4,133 | ) | (7 | ) | |||||
Other income (expense), net | (793 | ) | (668 | ) | 130 | ||||||
Total interest and other income (expense), net | (4,823 | ) | (4,800 | ) | 269 | ||||||
Income (loss) before income taxes | (10,489 | ) | (15,443 | ) | 8,591 | ||||||
Income tax provision (benefit) | 8,959 | (6,276 | ) | 243 | |||||||
Net income (loss) | $ | (19,448 | ) | $ | (9,167 | ) | $ | 8,348 | |||
Net income (loss) per share: | |||||||||||
Basic | $ | (0.29 | ) | $ | (0.14 | ) | $ | 0.13 | |||
Diluted | $ | (0.29 | ) | $ | (0.14 | ) | $ | 0.12 | |||
Shares used to compute net income (loss) per share: | |||||||||||
Basic | 67,147 | 66,712 | 64,752 | ||||||||
Diluted | 67,147 | 66,712 | 68,421 | ||||||||
Years Ended | |||||||
December 31, 2017 | December 31, 2016 | ||||||
Net revenue | $ | 420,318 | $ | 387,832 | |||
Cost of net revenue | 212,355 | 157,842 | |||||
Gross profit | 207,963 | 229,990 | |||||
Operating expenses: | |||||||
Research and development | 112,279 | 97,745 | |||||
Selling, general and administrative | 105,831 | 64,454 | |||||
IPR&D impairment losses | 2,000 | 1,300 | |||||
Restructuring charges | 9,524 | 3,432 | |||||
Total operating expenses | 229,634 | 166,931 | |||||
Income (loss) from operations | (21,671 | ) | 63,059 | ||||
Interest income | 274 | 572 | |||||
Interest expense | (10,378 | ) | (104 | ) | |||
Other income (expense), net | (2,223 | ) | 163 | ||||
Total interest and other income (expense), net | (12,327 | ) | 631 | ||||
Income (loss) before income taxes | (33,998 | ) | 63,690 | ||||
Income tax provision (benefit) | (24,811 | ) | 2,398 | ||||
Net income (loss) | $ | (9,187 | ) | $ | 61,292 | ||
Net income (loss) per share: | |||||||
Basic | $ | (0.14 | ) | $ | 0.96 | ||
Diluted | $ | (0.14 | ) | $ | 0.91 | ||
Shares used to compute net income (loss) per share: | |||||||
Basic | 66,252 | 63,781 | |||||
Diluted | 66,252 | 67,653 | |||||
Three Months Ended | |||||||||||
December 31, 2017 | September 30, 2017 | December 31, 2016 | |||||||||
Operating Activities | |||||||||||
Net income (loss) | $ | (19,448 | ) | $ | (9,167 | ) | $ | 8,348 | |||
Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||||||||||
Amortization and depreciation | 20,236 | 21,342 | 7,960 | ||||||||
Impairment of IPR&D assets | — | 2,000 | — | ||||||||
Provision for losses on accounts receivable | — | 46 | — | ||||||||
Amortization of investment premiums, net | — | — | 74 | ||||||||
Amortization of inventory step-up | 9,715 | 10,207 | 2,652 | ||||||||
Amortization of debt issuance costs | 287 | 301 | — | ||||||||
Stock-based compensation | 7,770 | 7,796 | 5,290 | ||||||||
Deferred income taxes | 16,650 | (1,163 | ) | (114 | ) | ||||||
(Gain) loss on disposal of property and equipment | (33 | ) | 286 | 318 | |||||||
(Gain) loss on foreign currency | 738 | 733 | (282 | ) | |||||||
Excess tax benefits on stock-based awards | (1,961 | ) | (841 | ) | (2,249 | ) | |||||
Change in fair value of contingent consideration | — | — | 11 | ||||||||
Impairment of leases | — | — | 388 | ||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 9,492 | 7,063 | (815 | ) | |||||||
Inventory | 543 | 5,060 | 2,882 | ||||||||
Prepaid expenses and other assets | (424 | ) | 2,374 | 767 | |||||||
Accounts payable, accrued expenses and other current liabilities | (2,494 | ) | (17,453 | ) | 752 | ||||||
Accrued compensation | 1,351 | 1,498 | 2,252 | ||||||||
Deferred revenue and deferred profit | (12,862 | ) | 3,907 | 697 | |||||||
Accrued price protection liability | (6,658 | ) | 3,606 | (1,936 | ) | ||||||
Other long-term liabilities | (1,159 | ) | 144 | 608 | |||||||
Net cash provided by operating activities | 21,743 | 37,739 | 27,603 | ||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | (3,070 | ) | (2,500 | ) | (1,684 | ) | |||||
Proceeds from sale of property and equipment | 30 | — | — | ||||||||
Purchases of intangible assets | — | (53 | ) | — | |||||||
Purchases of available-for-sale securities | — | — | (10,044 | ) | |||||||
Maturities of available-for-sale securities | — | — | 10,185 | ||||||||
Net cash used in investing activities | (3,040 | ) | (2,553 | ) | (1,543 | ) | |||||
Financing Activities | |||||||||||
Net proceeds from issuance of common stock | 2,960 | 1,074 | 2,199 | ||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,718 | ) | (1,426 | ) | (1,132 | ) | |||||
Repayment of debt | (20,000 | ) | (50,000 | ) | — | ||||||
Net cash provided by (used in) financing activities | (18,758 | ) | (50,352 | ) | 1,067 | ||||||
Effect of exchange rate changes on cash and cash equivalents | 371 | (829 | ) | (307 | ) | ||||||
Increase (decrease) in cash, cash equivalents and restricted cash | 316 | (15,995 | ) | 26,820 | |||||||
Cash, cash equivalents and restricted cash at beginning of period | 74,096 | 90,091 | 56,076 | ||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 74,412 | $ | 74,096 | $ | 82,896 | |||||
Years Ended | |||||||
December 31, 2017 | December 31, 2016 | ||||||
Operating Activities | |||||||
Net income (loss) | $ | (9,187 | ) | $ | 61,292 | ||
Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||||||
Amortization and depreciation | 66,738 | 26,703 | |||||
Impairment of IPR&D assets | 2,000 | 1,300 | |||||
Provision for losses on accounts receivable | 133 | 87 | |||||
Amortization (accretion) of investment premiums (discount), net | (60 | ) | 169 | ||||
Amortization of inventory step-up | 25,557 | 5,641 | |||||
Amortization of debt issuance costs | 763 | — | |||||
Stock-based compensation | 32,668 | 21,765 | |||||
Deferred income taxes | (31,767 | ) | 101 | ||||
Loss on disposal of property and equipment | 168 | 366 | |||||
(Gain) loss on sale of available-for-sale securities | 38 | (50 | ) | ||||
(Gain) loss on foreign currency | 2,153 | (216 | ) | ||||
Excess tax benefits on stock-based awards | (8,559 | ) | (8,291 | ) | |||
Change in fair value of contingent consideration | — | 220 | |||||
Impairment of leases | — | 388 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (4,377 | ) | (8,175 | ) | |||
Inventory | (1,788 | ) | 9,846 | ||||
Prepaid expenses and other assets | 1,272 | 402 | |||||
Accounts payable, accrued expenses and other current liabilities | (1,918 | ) | 3,249 | ||||
Accrued compensation | 1,567 | 5,609 | |||||
Deferred revenue and deferred profit | (1,629 | ) | 1,925 | ||||
Accrued price protection liability | 6,395 | (4,850 | ) | ||||
Other long-term liabilities | (5,103 | ) | (164 | ) | |||
Net cash provided by operating activities | 75,064 | 117,317 | |||||
Investing Activities | |||||||
Purchases of property and equipment | (7,468 | ) | (8,512 | ) | |||
Proceeds from sale of property and equipment | 30 | — | |||||
Purchases of intangible assets | (5,378 | ) | (390 | ) | |||
Cash used in acquisition, net of cash acquired | (473,304 | ) | (101,000 | ) | |||
Purchases of available-for-sale securities | (30,577 | ) | (90,307 | ) | |||
Maturities of available-for-sale securities | 84,546 | 98,896 | |||||
Net cash used in investing activities | (432,151 | ) | (101,313 | ) | |||
Financing Activities | |||||||
Repurchases of common stock | (334 | ) | (3 | ) | |||
Net proceeds from issuance of common stock | 12,052 | 6,649 | |||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (11,543 | ) | (7,316 | ) | |||
Proceeds from issuance of debt | 416,846 | — | |||||
Repayment of debt | (70,000 | ) | — | ||||
Net cash provided by (used in) financing activities | 347,021 | (670 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | 1,582 | (394 | ) | ||||
Increase (decrease) in cash, cash equivalents and restricted cash | (8,484 | ) | 14,940 | ||||
Cash, cash equivalents and restricted cash at beginning of period | 82,896 | 67,956 | |||||
Cash, cash equivalents and restricted cash at end of period | $ | 74,412 | $ | 82,896 | |||
December 31, 2017 | September 30, 2017 | December 31, 2016 | |||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 71,872 | $ | 71,576 | $ | 81,086 | |||||
Short-term restricted cash | 1,476 | 615 | 614 | ||||||||
Short-term investments, available-for-sale | — | — | 47,918 | ||||||||
Accounts receivable, net | 66,099 | 75,618 | 50,487 | ||||||||
Inventory | 53,434 | 63,692 | 26,583 | ||||||||
Prepaid expenses and other current assets | 8,423 | 7,917 | 6,159 | ||||||||
Total current assets | 201,304 | 219,418 | 212,847 | ||||||||
Long-term restricted cash | 1,064 | 1,905 | 1,196 | ||||||||
Property and equipment, net | 22,658 | 23,336 | 20,549 | ||||||||
Long-term investments, available-for-sale | — | — | 5,991 | ||||||||
Intangible assets, net | 315,045 | 332,409 | 104,261 | ||||||||
Goodwill | 237,992 | 239,673 | 76,015 | ||||||||
Deferred tax assets | 39,878 | 53,985 | 116 | ||||||||
Other long-term assets | 6,921 | 6,288 | 1,677 | ||||||||
Total assets | $ | 824,862 | $ | 877,014 | $ | 422,652 | |||||
Liabilities and stockholders’ equity | |||||||||||
Current liabilities | $ | 76,386 | $ | 98,381 | $ | 54,543 | |||||
Long-term debt | 347,609 | 367,322 | — | ||||||||
Other long-term liabilities | 13,443 | 14,663 | 15,685 | ||||||||
Total stockholders’ equity | 387,424 | 396,648 | 352,424 | ||||||||
Total liabilities and stockholders’ equity | $ | 824,862 | $ | 877,014 | $ | 422,652 | |||||
Three Months Ended | |||||||||||
December 31, 2017 | September 30, 2017 | December 31, 2016 | |||||||||
GAAP gross profit | $ | 52,093 | $ | 51,842 | $ | 50,403 | |||||
Stock-based compensation | 101 | 93 | 59 | ||||||||
Performance based equity | 35 | 34 | 31 | ||||||||
Amortization of inventory step-up | 9,715 | 10,207 | 2,652 | ||||||||
Amortization of purchased intangible assets | 8,465 | 7,907 | 2,572 | ||||||||
Depreciation of fixed asset step-up | 112 | 113 | — | ||||||||
Deferred profit eliminated in purchase price accounting | — | 810 | — | ||||||||
Non-GAAP gross profit | 70,521 | 71,006 | 55,717 | ||||||||
GAAP R&D expenses | 30,116 | 29,270 | 24,035 | ||||||||
Stock-based compensation | (4,349 | ) | (4,337 | ) | (3,319 | ) | |||||
Incentive award compensation | — | — | (169 | ) | |||||||
Performance based equity | (1,031 | ) | (961 | ) | (1,133 | ) | |||||
Amortization of purchased intangible assets | (97 | ) | (96 | ) | (97 | ) | |||||
Depreciation of fixed asset step-up | (297 | ) | (561 | ) | — | ||||||
Restricted merger proceeds and contingent consideration | — | — | (35 | ) | |||||||
Non-GAAP R&D expenses | 24,342 | 23,315 | 19,282 | ||||||||
GAAP SG&A expenses | 26,843 | 29,037 | 16,720 | ||||||||
Stock-based compensation | (3,105 | ) | (2,965 | ) | (1,724 | ) | |||||
Incentive award compensation | — | — | (18 | ) | |||||||
Performance based equity | (937 | ) | (517 | ) | (673 | ) | |||||
Amortization of purchased intangible assets | (8,760 | ) | (9,924 | ) | (2,914 | ) | |||||
Depreciation of fixed asset step-up | (20 | ) | (30 | ) | — | ||||||
Acquisition and integration costs | (54 | ) | (1,005 | ) | (572 | ) | |||||
Restricted merger proceeds and contingent consideration | — | — | (11 | ) | |||||||
IP litigation costs, net | (38 | ) | (4 | ) | (28 | ) | |||||
Non-GAAP SG&A expenses | 13,929 | 14,592 | 10,780 | ||||||||
GAAP IPR&D impairment losses | — | 2,000 | — | ||||||||
IPR&D impairment losses | — | (2,000 | ) | — | |||||||
Non-GAAP IPR&D impairment losses | — | — | — | ||||||||
GAAP restructuring expenses | 800 | 2,178 | 1,326 | ||||||||
Restructuring charges | (800 | ) | (2,178 | ) | (1,326 | ) | |||||
Non-GAAP restructuring expenses | — | — | — | ||||||||
GAAP income (loss) from operations | (5,666 | ) | (10,643 | ) | 8,322 | ||||||
Total non-GAAP adjustments | 37,916 | 43,742 | 17,333 | ||||||||
Non-GAAP income from operations | 32,250 | 33,099 | 25,655 | ||||||||
GAAP and non-GAAP interest and other income (expense), net | (4,823 | ) | (4,800 | ) | 269 | ||||||
GAAP income (loss) before income taxes | (10,489 | ) | (15,443 | ) | 8,591 | ||||||
Total non-GAAP adjustments | 37,916 | 43,742 | 17,333 | ||||||||
Non-GAAP income before income taxes | 27,427 | 28,299 | 25,924 | ||||||||
GAAP income tax provision (benefit) | 8,959 | (6,276 | ) | 243 | |||||||
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act | (7,853 | ) | 7,476 | (13 | ) | ||||||
Non-GAAP income tax provision | 1,106 | 1,200 | 230 | ||||||||
GAAP net income (loss) | (19,448 | ) | (9,167 | ) | 8,348 | ||||||
Total non-GAAP adjustments before income taxes | 37,916 | 43,742 | 17,333 | ||||||||
Less: total tax adjustments | (7,853 | ) | 7,476 | (13 | ) | ||||||
Non-GAAP net income | $ | 26,321 | $ | 27,099 | $ | 25,694 | |||||
Shares used in computing non-GAAP basic net income per share | 67,147 | 66,712 | 64,752 | ||||||||
Shares used in computing non-GAAP diluted net income per share | 70,175 | 69,668 | 68,421 | ||||||||
Non-GAAP basic net income per share | $ | 0.39 | $ | 0.41 | $ | 0.40 | |||||
Non-GAAP diluted net income per share | $ | 0.38 | $ | 0.39 | $ | 0.38 | |||||
Years Ended | |||||||
December 31, 2017 | December 31, 2016 | ||||||
GAAP gross profit | $ | 207,963 | $ | 229,990 | |||
Stock-based compensation | 332 | 210 | |||||
Performance based equity | 139 | (10 | ) | ||||
Amortization of inventory step-up | 25,557 | 5,641 | |||||
Amortization of purchased intangible assets | 25,316 | 8,512 | |||||
Depreciation of fixed asset step-up | 337 | — | |||||
Deferred profit eliminated in purchase price accounting | 4,682 | — | |||||
Non-GAAP gross profit | 264,326 | 244,343 | |||||
GAAP R&D expenses | 112,279 | 97,745 | |||||
Stock-based compensation | (16,190 | ) | (13,681 | ) | |||
Incentive award compensation | — | (722 | ) | ||||
Performance based equity | (4,001 | ) | (4,707 | ) | |||
Amortization of purchased intangible assets | (386 | ) | (386 | ) | |||
Depreciation of fixed asset step-up | (1,618 | ) | — | ||||
Restricted merger proceeds and contingent consideration | — | (694 | ) | ||||
Non-GAAP R&D expenses | 90,084 | 77,555 | |||||
GAAP SG&A expenses | 105,831 | 64,454 | |||||
Stock-based compensation | (11,016 | ) | (7,014 | ) | |||
Incentive award compensation | — | (137 | ) | ||||
Performance based equity | (2,514 | ) | (2,951 | ) | |||
Amortization of purchased intangible assets | (28,827 | ) | (6,952 | ) | |||
Depreciation of fixed asset step-up | (106 | ) | — | ||||
Acquisition and integration costs | (10,062 | ) | (2,424 | ) | |||
Restricted merger proceeds and contingent consideration | — | (220 | ) | ||||
IP litigation costs, net | (272 | ) | (699 | ) | |||
Non-GAAP SG&A expenses | 53,034 | 44,057 | |||||
GAAP IPR&D impairment losses | 2,000 | 1,300 | |||||
IPR&D impairment losses | (2,000 | ) | (1,300 | ) | |||
Non-GAAP IPR&D impairment losses | — | — | |||||
GAAP restructuring expenses | 9,524 | 3,432 | |||||
Restructuring charges | (9,524 | ) | (3,432 | ) | |||
Non-GAAP restructuring expenses | — | — | |||||
GAAP income (loss) from operations | (21,671 | ) | 63,059 | ||||
Total non-GAAP adjustments | 142,879 | 59,672 | |||||
Non-GAAP income from operations | 121,208 | 122,731 | |||||
GAAP and non-GAAP interest and other income (expense), net | (12,327 | ) | 631 | ||||
GAAP income (loss) before income taxes | (33,998 | ) | 63,690 | ||||
Total non-GAAP adjustments | 142,879 | 59,672 | |||||
Non-GAAP income before income taxes | 108,881 | 123,362 | |||||
GAAP income tax provision (benefit) | (24,811 | ) | 2,398 | ||||
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act | 32,433 | (151 | ) | ||||
Non-GAAP income tax provision | 7,622 | 2,247 | |||||
GAAP net income (loss) | (9,187 | ) | 61,292 | ||||
Total non-GAAP adjustments before income taxes | 142,879 | 59,672 | |||||
Less: total tax adjustments | 32,433 | (151 | ) | ||||
Non-GAAP net income | $ | 101,259 | $ | 121,115 | |||
Shares used in computing non-GAAP basic net income per share | 66,252 | 63,781 | |||||
Shares used in computing non-GAAP diluted net income per share | 69,665 | 67,653 | |||||
Non-GAAP basic net income per share | $ | 1.53 | $ | 1.90 | |||
Non-GAAP diluted net income per share | $ | 1.45 | $ | 1.79 | |||
Three Months Ended | ||||||||
December 31, 2017 | September 30, 2017 | December 31, 2016 | ||||||
GAAP gross profit | 45.8 | % | 45.6 | % | 57.8 | % | ||
Stock-based compensation | 0.1 | % | 0.1 | % | 0.1 | % | ||
Performance based equity | — | % | — | % | — | % | ||
Amortization of inventory step-up | 8.5 | % | 9.0 | % | 3.0 | % | ||
Amortization of purchased intangible assets | 7.4 | % | 7.0 | % | 3.0 | % | ||
Depreciation of fixed asset step-up | 0.2 | % | 0.1 | % | — | % | ||
Deferred profit eliminated in purchase price accounting | — | % | 0.7 | % | — | % | ||
Non-GAAP gross profit | 62.0 | % | 62.5 | % | 63.9 | % | ||
GAAP R&D expenses | 26.5 | % | 25.8 | % | 27.6 | % | ||
Stock-based compensation | (3.8 | )% | (3.8 | )% | (3.9 | )% | ||
Incentive award compensation | — | % | — | % | (0.2 | )% | ||
Performance based equity | (1.0 | )% | (0.9 | )% | (1.3 | )% | ||
Amortization of purchased intangible assets | (0.1 | )% | (0.1 | )% | (0.1 | )% | ||
Depreciation of fixed asset step-up | (0.2 | )% | (0.5 | )% | — | % | ||
Restricted merger proceeds and contingent consideration | — | % | — | % | — | % | ||
Non-GAAP R&D expenses | 21.4 | % | 20.5 | % | 22.1 | % | ||
GAAP SG&A expenses | 23.6 | % | 25.6 | % | 19.2 | % | ||
Stock-based compensation | (2.7 | )% | (2.6 | )% | (2.0 | )% | ||
Incentive award compensation | — | % | — | % | — | % | ||
Performance based equity | (1.0 | )% | (0.5 | )% | (0.8 | )% | ||
Amortization of purchased intangible assets | (7.7 | )% | (8.7 | )% | (3.3 | )% | ||
Depreciation of fixed asset step-up | — | % | (0.1 | )% | — | % | ||
Acquisition and integration costs | — | % | (0.9 | )% | (0.7 | )% | ||
Restricted merger proceeds and contingent consideration | — | % | — | % | — | % | ||
IP litigation costs, net | — | % | — | % | — | % | ||
Non-GAAP SG&A expenses | 12.2 | % | 12.8 | % | 12.4 | % | ||
GAAP IPR&D impairment losses | — | % | 1.8 | % | — | % | ||
IPR&D impairment losses | — | % | (1.8 | )% | — | % | ||
Non-GAAP IPR&D impairment losses | — | % | — | % | — | % | ||
GAAP restructuring expenses | 0.7 | % | 1.9 | % | 1.5 | % | ||
Restructuring charges | (0.7 | )% | (1.9 | )% | (1.5 | )% | ||
Non-GAAP restructuring expenses | — | % | — | % | — | % | ||
GAAP income (loss) from operations | (5.0 | )% | (9.4 | )% | 9.7 | % | ||
Total non-GAAP adjustments | 33.3 | % | 38.5 | % | 19.8 | % | ||
Non-GAAP income from operations | 28.3 | % | 29.1 | % | 29.5 | % | ||
GAAP and non-GAAP interest and other income (expense), net | (4.2 | )% | (4.2 | )% | 0.3 | % | ||
GAAP income (loss) before income taxes | (9.2 | )% | (13.6 | )% | 9.9 | % | ||
Total non-GAAP adjustments before income taxes | 33.3 | % | 38.5 | % | 19.8 | % | ||
Non-GAAP income before income taxes | 24.1 | % | 24.9 | % | 29.7 | % | ||
GAAP income tax provision (benefit) | 7.9 | % | (5.5 | )% | 0.3 | % | ||
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act | (7.0 | )% | 6.5 | % | — | % | ||
Non-GAAP income tax provision | 0.9 | % | 1.1 | % | 0.3 | % | ||
GAAP net income (loss) | (17.1 | )% | (8.1 | )% | 9.6 | % | ||
Total non-GAAP adjustments before income taxes | 33.3 | % | 38.5 | % | 19.8 | % | ||
Less: total tax adjustments | (7.0 | )% | 6.5 | % | — | % | ||
Non-GAAP net income | 23.1 | % | 23.9 | % | 29.5 | % | ||
Years Ended | |||||
December 31, 2017 | December 31, 2016 | ||||
GAAP gross profit | 49.5 | % | 59.3 | % | |
Stock-based compensation | 0.1 | % | 0.1 | % | |
Performance based equity | — | % | — | % | |
Amortization of inventory step-up | 6.0 | % | 1.5 | % | |
Amortization of purchased intangible assets | 6.0 | % | 2.1 | % | |
Depreciation of fixed asset step-up | 0.2 | % | — | % | |
Deferred profit eliminated in purchase price accounting | 1.1 | % | — | % | |
Non-GAAP gross profit | 62.9 | % | 63.0 | % | |
GAAP R&D expenses | 26.7 | % | 25.2 | % | |
Stock-based compensation | (3.9 | )% | (3.5 | )% | |
Incentive award compensation | — | % | (0.2 | )% | |
Performance based equity | (1.0 | )% | (1.2 | )% | |
Amortization of purchased intangible assets | (0.1 | )% | (0.1 | )% | |
Depreciation of fixed asset step-up | (0.3 | )% | — | % | |
Restricted merger proceeds and contingent consideration | — | % | (0.2 | )% | |
Non-GAAP R&D expenses | 21.4 | % | 20.0 | % | |
GAAP SG&A expenses | 25.2 | % | 16.6 | % | |
Stock-based compensation | (2.6 | )% | (1.8 | )% | |
Incentive award compensation | — | % | — | % | |
Performance based equity | (0.6 | )% | (0.7 | )% | |
Amortization of purchased intangible assets | (6.9 | )% | (1.8 | )% | |
Depreciation of fixed asset step-up | — | % | — | % | |
Acquisition and integration costs | (2.4 | )% | (0.6 | )% | |
Restricted merger proceeds and contingent consideration | — | % | (0.1 | )% | |
IP litigation costs, net | (0.1 | )% | (0.2 | )% | |
Non-GAAP SG&A expenses | 12.6 | % | 11.4 | % | |
GAAP IPR&D impairment losses | 0.5 | % | 0.3 | % | |
IPR&D impairment losses | (0.5 | )% | (0.3 | )% | |
Non-GAAP IPR&D impairment losses | — | % | — | % | |
GAAP restructuring expenses | 2.3 | % | 0.9 | % | |
Restructuring charges | (2.3 | )% | (0.9 | )% | |
Non-GAAP restructuring expenses | — | % | — | % | |
GAAP income (loss) from operations | (5.2 | )% | 16.2 | % | |
Total non-GAAP adjustments | 34.0 | % | 15.4 | % | |
Non-GAAP income from operations | 28.8 | % | 31.6 | % | |
GAAP and non-GAAP interest and other income (expense), net | (2.9 | )% | 0.2 | % | |
GAAP income (loss) before income taxes | (8.1 | )% | 16.4 | % | |
Total non-GAAP adjustments before income taxes | 34.0 | % | 15.4 | % | |
Non-GAAP income before income taxes | 25.9 | % | 31.8 | % | |
GAAP income tax provision (benefit) | (5.9 | )% | 0.6 | % | |
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act | 7.7 | % | — | % | |
Non-GAAP income tax provision | 1.8 | % | 0.6 | % | |
GAAP net income (loss) | (2.2 | )% | 15.8 | % | |
Total non-GAAP adjustments before income taxes | 34.0 | % | 15.4 | % | |
Less: total tax adjustments | 7.7 | % | — | % | |
Non-GAAP net income | 24.1 | % | 31.2 | % | |